This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Health Care

October 22 Premarket Briefing: 10 Things You Should Know

U.S. stock futures point lower; Yahoo! reports sharply better-than-expected earnings; Boeing and AT&T to post earnings reports; J&J to begin testing Ebola vaccine.

10/22/14 - 06:36 AM EDT

October 21 Premarket Briefing: 10 Things You Should Know

U.S. stock futures rise; Apple blows past earnings estimates; Verizon, Coke and McDonald's to report earnings on Tuesday.

10/21/14 - 06:46 AM EDT

Try Jim Cramer's Action Alerts PLUS
Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear

Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear

  • Tickers in this article:
  • IBIO
  • RAI

Ebola stocks have soared in recent weeks but a closer look at fundamentals may serve as a reality check for investors playing the story.

10/21/14 - 06:10 AM EDT

First Detailed Look at Celgene Crohn's Disease Pill Impresses

First Detailed Look at Celgene Crohn's Disease Pill Impresses

As a pill, Celgene's GED-031 (also known as mongersen) has the potential to become a preferred Crohn's therapy over injectable drugs like Abbvie's top-selling Humira.

10/20/14 - 10:56 AM EDT

Chimerix Gets FDA OK to Test Experimental Drug for Ebola

  • Tickers in this article:
  • CMRX

A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

10/17/14 - 03:26 PM EDT

One Reason UnitedHealth Group (UNH) Stock Is Up Today

One Reason UnitedHealth Group (UNH) Stock Is Up Today

  • Tickers in this article:
  • UNH

Shares of UnitedHealth Group (UNH) are higher in morning trading Friday after the company was upgraded to 'outperform' from 'market perform' at Leerink Partners.

10/17/14 - 11:53 AM EDT

Frontier Airlines Notifying More Passengers of Minor Ebola Risks

  • Tickers in this article:
  • FRNT

Frontier Airlines is notifying passengers on seven flights that they either flew with a nurse who later tested positive for Ebola or on a later flight using the same plane.

10/17/14 - 09:15 AM EDT

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech columnist Adam Feuerstein answers readers' questions about health care.

10/17/14 - 07:05 AM EDT

AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?

AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?

Bristol-Myers Squibb once showed interest in Shire. With AbbVie out of the way, could deal talks between Bristol-Myers and Shire resume? Here's why a Bristol-Myers and Shire deal makes sense.

10/16/14 - 08:10 PM EDT

Ebola Nurse’s Cleveland Visit: 18 Other Nurses on Same Flight

Ebola Nurse’s Cleveland Visit: 18 Other Nurses on Same Flight

  • Tickers in this article:
  • BRDCY
  • GT

Where did Ebola victim Amber Vinson go and what did she do in Cleveland and Akron? Here's what we know now.

10/16/14 - 03:29 PM EDT

AbbVie Drops Plan for $55 Billion Takeover of Drugmaker Shire

AbbVie Drops Plan for $55 Billion Takeover of Drugmaker Shire

AbbVie's board is recommending stockholders vote against its $55 billion takeover offer for drugmaker Shire after tax changes reduced the financial advantages of the deal.

10/16/14 - 05:56 AM EDT

FDA Approves Competing Lung Disease Drugs From Roche and Boehringer

FDA Approves Competing Lung Disease Drugs From Roche and Boehringer

  • Tickers in this article:
  • RHHBY

U.S. patients suffering from idiopathic pulmonary fibrosis finally gain access to Esbriet, approved for use in Europe since early 2011.

10/15/14 - 04:07 PM EDT

Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths

Stock Weakness in Seattle Genetics, Gilead Sciences Belies Fundamental Strengths

Some perspective on recent positive news, which nonetheless, caused Seattle Genetics and Gilead shares to fall.

10/15/14 - 09:35 AM EDT

U.K. Leads European Markets Lower as AbbVie Backs Away from Shire Deal

European markets remain in the red, amid mounting panic about the prospect of a euro-zone recession.

10/15/14 - 07:53 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs